SanjeeveBalasubramaniamMDMPH

PubMed

• 82 citations
  FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
  , , , , , , , , , , , , , , , , , , > ;The Oncologist. 2021 Jan 1
• 55 citations
  FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis
  Shaily Arora, Sanjeeve Balasubramaniam, Wei Zhang, Lijun Zhang, Rajeshwari Sridhara, Dianne Spillman, Jaigi P Mathai, Bradley J. Scott, Sarah J. Golding, Michael Coory...> ;Clinical Cancer Research. 2020 Oct 1
• 12 citations
  Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer
  Jaydira Del Rivero, Maureen Edgerly, Jean Ward, Ravi A. Madan, Sanjeeve Balasubramaniam, Tito Fojo, Ann Wild Gramza> ;The Oncologist. 2019 Jan 1
• 2 citations
  A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat.
  Cody J. Peer, Oliver Morgan Hall, Tristan M. Sissung, Richard Piekarz, Sanjeeve Balasubramaniam, Susan E. Bates, William D. Figg> ;Cancer Chemotherapy and Pharmacology. 2018 Jun 27
• 31 citations
  Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung.
  Sanjeeve Balasubramaniam, Christophe E. Redon, Cody J. Peer, Christine Bryla, Min-Jung Lee, Jane B. Trepel, Yusuke Tomita, Arun Rajan, Giuseppe Giaccone, William M. Bo...> ;Anti-Cancer Drugs. 2018 Jun 1
• 21 citations
  Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy
  Irfan Jawed, Margarita Velarde, Roland Därr, Katherine I. Wolf, Karen T. Adams, Aradhana M. Venkatesan, Sanjeeve Balasubramaniam, Marianne S. Poruchynsky, James C. Rey...> ;Cellular and Molecular Neurobiology. 2018 Apr 5
• 93 citations
  Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
  Julia A. Beaver, Maitreyee Hazarika, Flora Mulkey, Sirisha Mushti, Huanyu Chen, Kun He, Rajeshwari Sridhara, Kirsten B. Goldberg, Meredith K. Chuk, Dow Chung Chi, Jenn...> ;The Lancet. Oncology. 2018 Feb 1
• 99 citations
  FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation–Associated Advanced Ovarian Cancer
  Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton, Laura L. Fernandes, Shenghui Tang, Hisani N. Horne, Jinzhong Liu, Chao Liu, Sarah J. Schrieber, Jingyu Yu, Peng...> ;Clinical Cancer Research. 2017 Dec 1
• 35 citations
  FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.
  Thomas J. Herzog, Gwynn Ison, Ronald D. Alvarez, Sanjeeve Balasubramaniam, Deborah K. Armstrong, Julia A. Beaver, Annie Ellis, Shenghui Tang, Peg Ford, Amy E. McKee, D...> ;Gynecologic Oncology. 2017 Oct 1
• 3 citations
  A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.
  Mauricio Burotto, Maureen Edgerly, Margarita Velarde, Sanjeeve Balasubramaniam, Harry A. Drabkin, Juan G. Gormaz, Ciara C. O’Sullivan, Ravi A. Madan, Tito Fojo> ;The Oncologist. 2017 Aug 1
• 2 citations
  Regulatory considerations on endpoints in ovarian cancer drug development.
  Sanjeeve Balasubramaniam, Geoffrey Kim, Amy E. McKee, Richard Pazdur> ;Cancer. 2017 May 12
• 12 citations
  Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.
  Eden C. Payabyab, Sanjeeve Balasubramaniam, Maureen Edgerly, Margarita Velarde, Maria Merino, Aradhana M. Venkatesan, Harshraj Leuva, Thomas Litman, Susan E. Bates, Ti...> ;Clinical Cancer Research. 2016 Oct 15
• 21 citations
  ANG1005 for breast cancer brain metastases: correlation between 18 F-FLT–PET after first cycle and MRI in response assessment
  Ciara C. O’Sullivan, Maria Liza Lindenberg, Christine Bryla, N. Patronas, Cody J. Peer, Laleh Amiri-Kordestani, Nicole N. Davarpanah, E. M. Gonzalez, M. Burotto, Peter...> ;Breast Cancer Research and Treatment. 2016 Sep 12
• 16 citations
  UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
  Cody J. Peer, Andrew K. L. Goey, Tristan M. Sissung, Sheryl Erlich, Min-Jung Lee, Yusuke Tomita, Jane B. Trepel, Richard Piekarz, Sanjeeve Balasubramaniam, Susan E. Ba...> ;Journal of Clinical Pharmacology. 2016 Apr 1
• 27 citations
  Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer
  Andrew K. L. Goey, Tristan M. Sissung, Cody J. Peer, Jane B. Trepel, Min-Jung Lee, Yusuke Tomita, Sheryl Ehrlich, Christine Bryla, Sanjeeve Balasubramaniam, Richard Pi...> ;Journal of Clinical Pharmacology. 2016 Apr 1
• 23 citations
  Expansion Cohorts in First-in-Human Solid Tumor Oncology Trials
  Marc R. Theoret, Lee Pai-Scherf, Meredith K. Chuk, Tatiana M. Prowell, Sanjeeve Balasubramaniam, Kim Ts, Geoffrey Kim, Paul G. Kluetz, Patricia Keegan, Richard Pazdur> ;Clinical Cancer Research. 2015 Oct 15
• 24 citations
  Advancing Clinical Trials to Streamline Drug Development.
  Susan E. Bates, Donald A. Berry, Sanjeeve Balasubramaniam, Stuart Bailey, Patricia LoRusso, Eric H. Rubin> ;Clinical Cancer Research. 2015 Oct 15
• 7 citations
  Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma
  Mauricio Burotto, Maureen Edgerly, Marianne S. Poruchynsky, Margarita Velarde, Julia Wilkerson, Herb Kotz, Susan E. Bates, Sanjeeve Balasubramaniam, Tito Fojo> ;The Oncologist. 2015 Jul 1
• 5 citations
  A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent
  Leonard Joseph Appleman, Sanjeeve Balasubramaniam, Robert A. Parise, Christine Bryla, Christophe E. Redon, Asako J. Nakamura, William M. Bonner, John Wright, Richard P...> ;Clinical Cancer Research. 2015 Feb 15
• 70 citations
  The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
  Ciara C. O’Sullivan, Maureen Edgerly, Margarita Velarde, Julia Wilkerson, Aradhana M. Venkatesan, Stefania Pittaluga, Sherry X. Yang, Dat Nguyen, Sanjeeve Balasubraman...> ;The Journal of Clinical Endocrinology and Metabolism. 2014 Jan 3
• 50 citations
  Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy
  Marko Jakopović, Anish Thomas, Sanjeeve Balasubramaniam, David S. Schrump, Giuseppe Giaccone, Susan E. Bates> ;Frontiers in Oncology. 2013 Oct 9
• 28 citations
  Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans.
  Sanjeeve Balasubramaniam, Elaine Ron, Gloria Gridley, Arthur B. Schneider, Alina V. Brenner> ;The Journal of Clinical Endocrinology and Metabolism. 2012 May 8
• 22 citations
  Practical Considerations in the Evaluation and Management of Adrenocortical Cancer
  Sanjeeve Balasubramaniam, Tito Fojo> ;Seminars in Oncology. 2010 Dec 1
• 98 citations
  Vaccine-Stimulated, Adoptively Transferred CD8+ T Cells Traffic Indiscriminately and Ubiquitously while Mediating Specific Tumor Destruction
  Douglas C. Palmer, Sanjeeve Balasubramaniam, Ken-ichi Hanada, Claudia Wrzesinski, Zhiya Yu, Shahram Farid, Marc R. Theoret, Leroy N. Hwang, Christopher A. Klebanoff, L...> ;Journal of Immunology. 2004 Dec 15
• Join now to see all